v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series B Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2023   54,745          
Beginning balance at Dec. 31, 2023 $ 40,564 $ 1 $ 2,567 $ (48) $ 324,191 $ 20 $ (286,167)
Common stock, beginning balance (in shares) at Dec. 31, 2023     256,688,304        
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense 1,761       1,761    
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)     758,460        
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (145)   $ 8   (153)    
Other comprehensive income (loss) 5         5  
Net loss (11,924)           (11,924)
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2024   54,745          
Ending balance at Mar. 31, 2024 30,261 $ 1 $ 2,575 (48) 325,799 25 (298,091)
Common stock, ending balance (in shares) at Mar. 31, 2024     257,446,764        
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2023   54,745          
Beginning balance at Dec. 31, 2023 40,564 $ 1 $ 2,567 (48) 324,191 20 (286,167)
Common stock, beginning balance (in shares) at Dec. 31, 2023     256,688,304        
Increase (Decrease) in Stockholders' Equity              
Net loss (27,204)            
Convertible preferred stock, ending balance (in shares) at Jun. 30, 2024   0          
Ending balance at Jun. 30, 2024 16,927 $ 0 $ 2,576 (48) 327,742 28 (313,371)
Common stock, ending balance (in shares) at Jun. 30, 2024     257,542,624        
Convertible preferred stock, beginning balance (in shares) at Mar. 31, 2024   54,745          
Beginning balance at Mar. 31, 2024 30,261 $ 1 $ 2,575 (48) 325,799 25 (298,091)
Common stock, beginning balance (in shares) at Mar. 31, 2024     257,446,764        
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense 1,898       1,898    
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)     95,860        
Issuance of common stock for stock option exercises and restricted stock unit vesting, net 45   $ 1   44    
Series B convertible preferred stock conversion (in shares)   (54,745)          
Series B convertible preferred stock conversion 0 $ (1)     1    
Other comprehensive income (loss) 3         3  
Net loss (15,280)           (15,280)
Convertible preferred stock, ending balance (in shares) at Jun. 30, 2024   0          
Ending balance at Jun. 30, 2024 16,927 $ 0 $ 2,576 (48) 327,742 28 (313,371)
Common stock, ending balance (in shares) at Jun. 30, 2024     257,542,624        
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2024   0          
Beginning balance at Dec. 31, 2024 $ 29,632 $ 0 $ 2,915 (48) 366,938 48 (340,221)
Common stock, beginning balance (in shares) at Dec. 31, 2024 291,367,558   291,489,058        
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense $ 1,885       1,885    
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)     660,917        
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (245)   $ 7   (252)    
Other comprehensive income (loss) (8)         (8)  
Net loss (15,350)           (15,350)
Convertible preferred stock, ending balance (in shares) at Mar. 31, 2025   0          
Ending balance at Mar. 31, 2025 15,914 $ 0 $ 2,922 (48) 368,571 40 (355,571)
Common stock, ending balance (in shares) at Mar. 31, 2025     292,149,975        
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2024   0          
Beginning balance at Dec. 31, 2024 $ 29,632 $ 0 $ 2,915 (48) 366,938 48 (340,221)
Common stock, beginning balance (in shares) at Dec. 31, 2024 291,367,558   291,489,058        
Increase (Decrease) in Stockholders' Equity              
Net loss $ (30,089)            
Convertible preferred stock, ending balance (in shares) at Jun. 30, 2025   0          
Ending balance at Jun. 30, 2025 $ 3,052 $ 0 $ 2,924 (48) 370,474 12 (370,310)
Common stock, ending balance (in shares) at Jun. 30, 2025 292,192,061   292,313,561        
Convertible preferred stock, beginning balance (in shares) at Mar. 31, 2025   0          
Beginning balance at Mar. 31, 2025 $ 15,914 $ 0 $ 2,922 (48) 368,571 40 (355,571)
Common stock, beginning balance (in shares) at Mar. 31, 2025     292,149,975        
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense 1,844       1,844    
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)     163,586        
Issuance of common stock for stock option exercises and restricted stock unit vesting, net 61   $ 2   59    
Other comprehensive income (loss) (28)         (28)  
Net loss (14,739)           (14,739)
Convertible preferred stock, ending balance (in shares) at Jun. 30, 2025   0          
Ending balance at Jun. 30, 2025 $ 3,052 $ 0 $ 2,924 $ (48) $ 370,474 $ 12 $ (370,310)
Common stock, ending balance (in shares) at Jun. 30, 2025 292,192,061   292,313,561